Skip to main content

People in the News: Ronald Wapner, Erik Christensen, Henrik Lund, Ingrid Wiik


CombiMatrix has named Ronald Wapner, a physician and specialist in reproductive genetics, to serve on its scientific advisory board. Wapner is vice chair for research in obstetrics and gynecology for Columbia University Medical Center and director of reproductive genetics. He also was principal investigator for a National Institute of Child Health and Human Development-sponsored multi-center study comparing chromosomal microarray testing to karyotyping (BAN 2/14/2012).

Diagenic said this week that CEO Erik Christensen has resigned from his position, and the company has named Henrik Lund, chairman of the board of directors, to step in as interim CEO. Lund has left his position on the board to Ingrid Wiik, who is deputy chairman of the board, until the annual general meeting in June. Christensen had been CEO since 2007.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.